INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
NYSE:INSP • US4577301090
59.25 USD
+1.53 (+2.65%)
At close: Feb 25, 2026
59.25 USD
0 (0%)
After Hours: 2/25/2026, 8:21:31 PM
Overall INSP gets a fundamental rating of 6 out of 10. We evaluated INSP against 185 industry peers in the Health Care Equipment & Supplies industry. INSP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INSP is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year INSP was profitable.
- INSP had a positive operating cash flow in the past year.
- In multiple years INSP reported negative net income over the last 5 years.
- The reported operating cash flow has been mixed in the past 5 years: INSP reported negative operating cash flow in multiple years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 5.52%, INSP belongs to the top of the industry, outperforming 82.70% of the companies in the same industry.
- INSP's Return On Equity of 6.69% is fine compared to the rest of the industry. INSP outperforms 80.00% of its industry peers.
- With a decent Return On Invested Capital value of 4.82%, INSP is doing good in the industry, outperforming 74.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROIC | 4.82% |
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- INSP has a Profit Margin of 5.05%. This is in the better half of the industry: INSP outperforms 77.30% of its industry peers.
- INSP has a better Operating Margin (4.16%) than 68.11% of its industry peers.
- Looking at the Gross Margin, with a value of 84.92%, INSP belongs to the top of the industry, outperforming 94.59% of the companies in the same industry.
- INSP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INSP is destroying value.
- INSP has less shares outstanding than it did 1 year ago.
- INSP has more shares outstanding than it did 5 years ago.
- INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 8.77 indicates that INSP is not in any danger for bankruptcy at the moment.
- With an excellent Altman-Z score value of 8.77, INSP belongs to the best of the industry, outperforming 88.11% of the companies in the same industry.
- There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.77 |
ROIC/WACC0.49
WACC9.88%
2.3 Liquidity
- INSP has a Current Ratio of 5.29. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
- INSP's Current ratio of 5.29 is fine compared to the rest of the industry. INSP outperforms 80.00% of its industry peers.
- A Quick Ratio of 4.01 indicates that INSP has no problem at all paying its short term obligations.
- INSP has a Quick ratio of 4.01. This is in the better half of the industry: INSP outperforms 75.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 |
3. Growth
3.1 Past
- INSP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.09%, which is quite impressive.
- The Revenue has grown by 13.60% in the past year. This is quite good.
- Measured over the past years, INSP shows a very strong growth in Revenue. The Revenue has been growing by 51.20% on average per year.
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%
3.2 Future
- The Earnings Per Share is expected to grow by 14.46% on average over the next years. This is quite good.
- Based on estimates for the next years, INSP will show a quite strong growth in Revenue. The Revenue will grow by 10.27% on average per year.
EPS Next Y-29.76%
EPS Next 2Y1.11%
EPS Next 3Y11.77%
EPS Next 5Y14.46%
Revenue Next Year7.01%
Revenue Next 2Y8.03%
Revenue Next 3Y9.22%
Revenue Next 5Y10.27%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 23.61, INSP is valued on the expensive side.
- 80.00% of the companies in the same industry are more expensive than INSP, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of INSP to the average of the S&P500 Index (27.05), we can say INSP is valued inline with the index average.
- INSP is valuated quite expensively with a Price/Forward Earnings ratio of 33.61.
- 69.73% of the companies in the same industry are more expensive than INSP, based on the Price/Forward Earnings ratio.
- When comparing the Price/Forward Earnings ratio of INSP to the average of the S&P500 Index (28.03), we can say INSP is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.61 | ||
| Fwd PE | 33.61 |
4.2 Price Multiples
- 72.43% of the companies in the same industry are more expensive than INSP, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of INSP indicates a rather cheap valuation: INSP is cheaper than 94.05% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.42 | ||
| EV/EBITDA | 24.11 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.11%
EPS Next 3Y11.77%
5. Dividend
5.1 Amount
- INSP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
59.25
+1.53 (+2.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11 2026-02-11/amc
Earnings (Next)05-04 2026-05-04/amc
Inst Owners111.59%
Inst Owner Change9.03%
Ins Owners0.74%
Ins Owner Change-0.28%
Market Cap1.72B
Revenue(TTM)911.98M
Net Income(TTM)44.56M
Analysts76.8
Price Target131.09 (121.25%)
Short Float %13.43%
Short Ratio2.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)-8.19%
PT rev (3m)15%
EPS NQ rev (1m)0.74%
EPS NQ rev (3m)30.36%
EPS NY rev (1m)-0.29%
EPS NY rev (3m)9.42%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)1%
Revenue NY rev (1m)-3.38%
Revenue NY rev (3m)-6.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.61 | ||
| Fwd PE | 33.61 | ||
| P/S | 1.95 | ||
| P/FCF | 17.42 | ||
| P/OCF | 12.88 | ||
| P/B | 2.58 | ||
| P/tB | 2.58 | ||
| EV/EBITDA | 24.11 |
EPS(TTM)2.51
EY4.24%
EPS(NY)1.76
Fwd EY2.98%
FCF(TTM)3.4
FCFY5.74%
OCF(TTM)4.6
OCFY7.76%
SpS30.37
BVpS22.93
TBVpS22.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.99
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROCE | 5.27% | ||
| ROIC | 4.82% | ||
| ROICexc | 8.98% | ||
| ROICexgc | 8.98% | ||
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% | ||
| FCFM | 11.2% |
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
F-Score8
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 276.46% | ||
| Cap/Sales | 3.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 270.95% | ||
| Profit Quality | 221.78% | ||
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 | ||
| Altman-Z | 8.77 |
F-Score8
WACC9.88%
ROIC/WACC0.49
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
EPS Next Y-29.76%
EPS Next 2Y1.11%
EPS Next 3Y11.77%
EPS Next 5Y14.46%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%
Revenue Next Year7.01%
Revenue Next 2Y8.03%
Revenue Next 3Y9.22%
Revenue Next 5Y10.27%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year694.28%
EBIT Next 3Y129.9%
EBIT Next 5Y70.54%
FCF growth 1Y158.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.68%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to INSP.
Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?
ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.
How profitable is INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.
What are the PE and PB ratios of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The Price/Earnings (PE) ratio for INSPIRE MEDICAL SYSTEMS INC (INSP) is 23.61 and the Price/Book (PB) ratio is 2.58.
What is the financial health of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.